drugset / Trial / NCT00911365

Trial of Autologous Mesenchymal Stem Cells in Patients With Multiple System Atrophy

NCT00911365 ↗

Phase 2 Completed 27 enrolled Yonsei University
RandomizedParallel-groupSingle-blindTreatment

Summary

This study is based on positive results in open label trial of mesenchymal stem cells therapy in patients with Multiple System Atrophy (MSA).

Timeline

Start
2008-05
Primary completion
2011-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous mesenchymal stem cells Cell therapy 4e+07 cells Other